ASHLEY LASSITER: Open Payments
NPI 1205414885 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,061 in 167 payments from 23 companies in 2025. Trend: 2023 $1,760 · 2024 $2,256 · 2025 $3,061
Food & beverage: $3,061
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 27 | $378 |
| AstraZeneca Pharmaceuticals LP | 14 | $371 |
| ABBVIE INC. | 31 | $351 |
| Abbott Laboratories | 12 | $273 |
| Lilly USA, LLC | 12 | $224 |
| Amgen Inc. | 13 | $216 |
| SHIELD THERAPEUTICS INC | 5 | $202 |
| Novo Nordisk Inc | 12 | $178 |
| Vanda Pharmaceuticals Inc. | 4 | $148 |
| Otsuka America Pharmaceutical, Inc. | 6 | $121 |
Products named: FREESTYLE LIBRE 3, ACCRUFER, FARXIGA, NURTEC ODT, FANAPT, OTEZLA, VRAYLAR, MOUNJARO.
Industry payments across MO — which companies pay providers there.
